# A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.

> **NCT00254618** · PHASE1 · TERMINATED · sponsor: **Warner Chilcott** · enrollment: 34 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** mesalamine
- **DRUG:** mesalamine
- **DRUG:** mesalamine

## Key facts

- **NCT ID:** NCT00254618
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Slow enrollment.
- **Last updated:** 2013-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00254618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00254618, "A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00254618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*